Peripheral blood mammaglobin gene expression for diagnosis and prediction of metastasis in breast cancer patients
- 4 July 2012
- journal article
- research article
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 9 (1) , 66-70
Abstract
To evaluate the value of peripheral blood mammaglobin (MG) gene expression for diagnosis and prediction of metastasis in breast cancer patients. MG expression was detected by nested reverse-transcription polymerase chain reaction in the peripheral blood of 46 females (32 breast cancer, 12 benign breast lesions, 2 no breast abnormalities). In total 28 breast cancer patients were followed up through a period of 34 months for the development of metastasis. MG expression was detected in 16/32 (50%) breast cancer patients but not in patients with benign lesions or healthy participants. Five patients had metastasis at diagnosis. During the 34 months of follow up, five more MG-positive patients showed metastatic lesions and none of the MG negative patients who were followed up developed metastasis. The study suggests blood MG expression is a specific molecular marker for detection of occult mammary carcinoma cells of patients with operable breast cancer. It might be of value as a predictor of subsequent metastasis. Large-scale studies and longer follow-up periods are needed.Keywords
This publication has 24 references indexed in Scilit:
- Identification of Mammaglobin as a Novel Serum Marker for Breast CancerClinical Cancer Research, 2005
- Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast CancerClinical Cancer Research, 2005
- Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patientsInternational Journal of Cancer, 2003
- Mammaglobin in Normal Human Sweat Glands and Human Sweat Gland TumorsJournal of Investigative Dermatology, 2003
- Purification and Characterization of the Mammaglobin/Lipophilin B Complex, a Promising Diagnostic Marker for Breast CancerBiochemistry, 2002
- Detection of mammaglobin in the sera of patients with breast cancer.Tumor Biology, 2002
- Detection of Circulating Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients Via a Nested Reverse Transcriptase Polymerase Chain Reaction Assay for Mammaglobin mRNAJournal of Clinical Oncology, 1999
- The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: Use, limitations and future of RNA-based methodsAnnals of Oncology, 1998
- Lipophilin, a novel heterodimeric protein of human tearsFEBS Letters, 1998
- Detection of Minimal Disease in Patients with Solid TumorsJournal of Hematotherapy, 1996